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Abstract. We present a physical model to describe iontophoresis time
recordings. The model is a combination of monodimensional material
diffusion and decay, probably due to transport by blood flow. It has
four adjustable parameters, the diffusion coefficient, the decay con-
stant, the height of the response, and the shot saturation constant, a
parameter representing the relative importance of subsequent shots in
case of saturation. We test the model with measurements of blood
perfusion in the capillary bed of the fingers of women who recently
had preeclampsia and in women with a history of normal pregnancy.
From the fits to the measurements, we conclude that the model pro-
vides a useful physical description of the iontophoresis process. © 2007
Society of Photo-Optical Instrumentation Engineers. DOI: 10.1117/1.2671053
Keywords: iontophoresis; flowmetry; pregnancy; laser-Doppler; tissue perfusion;
preeclampsia.
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1 Introduction
Iontophoresis is the introduction of charged substances into
the skin by means of a small electrical current. It is based on
the principle that a charged molecule migrates under the in-
fluence of an applied electrical field toward electrodes of op-
posite charge placed on tissue. Normally, one electrode con-
sists of a conductive sponge, containing the material to be
introduced. The other electrode is located some distance from
the first one. A comprehensive review of the method, together
with pharmaceutical, physiological, and experimental details,
has been published by Banga.1
Laser-Doppler perfusion flow monitoring (LDPM) mea-
sures the averaged blood flow in small dermis vessels. Coher-
ent light from a laser partly scatters in moving red blood cells
before emerging at the tissue surface. Due to the Doppler
effect, the frequency of the light will slightly change accord-
ing to the velocity of the cells. A photodiode, measuring both
the original laser light and the Doppler-shifted emerged light,
will produce a Doppler frequency signal. The strength of this
signal depends on the moving blood cell flow.
The combination of LDPM and iontophoresis offers an op-
portunity to assess changes in the cutaneous microcirculation
after administration of vaso-active drugs without systemic ef-
fects. Iontophoresis of sodium nitroprusside SNP, donating
directly nitric oxide, is commonly accepted to provoke
endothelium-independent vasodilatation, whereas iontophore-
sis of acetylcholine chloride ACh is commonly used to test
endothelium-dependent vasodilatation. The methodology us-
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ing iontophoresis and laser-Doppler flowmetry has been
widely used to investigate microvascular function in various
vascular disease states, most commonly in diabetes
mellitus.2,3
Endothelium activation or dysfunction plays an important
role in the clinical manifestations and pathophysiology of
preeclampsia, a serious pregnancy complication characterized
by hypertension, proteinuria, increased peripheral resistance,
and reduced organ perfusion. By using iontophoresis and
laser-Doppler flowmetry, increased responses of acetylcholine
were found in preeclampsia compared to normotensive
women.4 We previously showed that even 6 to 7 months after
delivery, ACh-mediated reactivity was observed to be in-
creased in women with a history of early-onset preeclampsia.5
Until now, clinical iontophoresis research has exclusively
concentrated on the relative height of the excess perfusion
signal, compared with that of the flux in resting conditions
the “resting flux”. However, when comparing time record-
ings of various groups of patients and healthy control per-
sons, we observed differences in the shape of the time record-
ings, in particular in the characteristic times of the onset of the
excess perfusion and of the return to resting flux conditions.
Therefore, we decided that it was worthwhile to investigate
these differences more thoroughly, and for that purpose, we
need means to quantify characteristics based on a physically
sound model.
A typical time recording of a laser-Doppler perfusion mea-
surement during the iontophoresis process is shown in Fig. 1.
The measurement starts with a recording of the resting flux.
This is followed by a series of shots, in which the electrical
current is applied. The result is an enhanced perfusion signal
climbing to a maximum value. After the shots, the perfusion
signal returns to the resting flux value.
The model should be able to describe the diffusion process
of the drug material into tissue. This process is governed by
the diffusion coefficient expressed in m2/s. In the case of
laser-Doppler iontophoresis measurements, the dimensions of
the optical probe are very small compared to those of the
exchange area, and thus we can describe the diffusion process
into tissue, as far as can be seen by the laser probe, as a
monodimensional process.
The model should also admit leakage of drug material due
to transport by blood flow out of the tissue under the ionto-
probe. However, this diffusion model does not include leak-
age of material other than toward infinite depth, and thus we
have to include an extra term for that purpose. Therefore, we
insert a decay function analogously to radioactive decay. Fur-
ther, since iontophoresis protocols frequently consist of sev-
eral subsequent shots, the model should take care of this. Fi-
nally, the model should be maximum protocol independent.
In the literature, some modeling of normal not electrically
sustained diffusion of molecules through membranes into tis-
sue has been published.1 Most models rely on Fick’s law6 of
material diffusion in one dimension. Flynn7 gives an overview
of several of these models, together with experimental data of
the permeability coefficients P in cm/h and the partition
coefficients K dimensionless for the material transfer at the
octanol/water partition, which is supposed to resemble the
stratum-corneum/water partition. He also indicates the rela-
tion with the diffusion coefficient D in cm2/s:
P = KD/h , 1
where h is the thickness of the membrane. This thickness is
normally taken as about 0.5 mm for tissue epidermis,8 and
500 nm for lipid layers.9 The latter authors also investigated
the permeability results of Flynn and others in extensive de-
tail.
A purely phenomenological model for iontophoresis diffu-
sion was presented by Özbebit et al.9 It consisted of one or
two hyperbolic time functions, but without underlying physi-
cal argumentation. This model only tries to describe the onset
of excess flow after the start of administering the material, but
not the whole time recording.
The study was a part of a broader investigation of pregnant
and nonpregnant women, with or without hypertensia, during
or after pregnancy.5 Since our present objective is to present
the model, we only present data for patients and control per-
sons postpartum. Other measurements will be published else-
where.
2 Model
Perfusion changes after iontophoresis were measured with
laser-Doppler perfusion flowmetry. Upon administering drugs
like ACh or SNP, a change in the blood perfusion is measured.
We assume that microvascular capillaries react by vasodilata-
tion, thus enlarging the blood perfusion either by an increase
in the number of moving red blood cells or by an increase in
their velocities. In both ways the transport of the administered
drug out of the region under examination will be favored.
The iontophoresis process is determined by the geometry
of the iontophoresis/laser-Doppler probe and the tissue region
that is measured. Normally, the probe will contain two or
more glass fibers for transport of the laser light, one for light
supply and one or more for the reflected light see Fig. 2. At
the tissue surface, these fibers are positioned at standardized
separation distances here 250 m. The diameter of the fi-
bers is typically 100 to 200 m. The fibers are placed in the
center of a larger container, with typical diameters of 10 to
20 mm and height of 10 mm. The container is filled with
sponge-like material, fit to store the drug to be administered,
and in electrical contact with the tissue. An electrode is con-
Fig. 1 Typical time recording of an iontophoresis provocation, as
measured with laser-Doppler perfusion flowmetry.
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nected to the sponge material, with another electrode to be
connected to the patient at a different place. The drug itself
must be electrically conductive. Upon applying a voltage dif-
ference over the two electrodes, the drug will be part of the
electrical circuit, and ionized molecules of the drug may dif-
fuse into the tissue. The number of molecules that actually
have diffused into the tissue can be estimated by registration
of the electric current strength and its time duration.
For the transport of drug molecules, we assume that two
mechanisms are present. The first is the diffusion of the ad-
ministered molecules from the probe into the tissue. Since the
separation between the two sets of glass fibers is small com-
pared with the dimensions of the sponge material in the probe,
we may consider the diffusion process as effectively 1-D,
with the depth z z0 into tissue as the coordinate variable.







with t as the time, cz , t as the concentration kg/m3, and D
as the diffusion coefficient m2/s.
This differential equation can be solved by introducing the
boundary conditions:
for times t 0: cz,t = 0, and




cz,t · dz = Q for all t, including t = 0.
3
Q stands for the total mass of material that is injected per m2
tissue surface area under the probe. Equation 3 means that at
t=0, a single shot is delivered at the boundary of the tissue,





exp− z24Dt . 4
In iontophoresis protocols, frequently a number of shots is
administered. We deal with that shortly. In Fig. 3a, this dif-
fusion function is sketched for inspection. It is seen that for
chosen values of z, the function first will increase and finally
decrease to zero.
The time functions decrease toward zero slowly, which is
due to the absence of leakage of material, other than toward
z→. In reality we have leakage of molecules out of the
measured volume in pharmacokinetics “distribution”, due to
transport by blood perfusion “elimination”. More generally,
the effect of the molecules on the perfusion may decrease in
time, either due to removal or to saturation effects or reduc-
tion in efficiency “tolerance”. This presents an extra term in
the differential equation, analogous to the term representing
decay, as with radioactive decay, or with a decrease of gas







− c , 5
with  as the decay constant 0, related to the “half-
value time” T1/2 by T1/2=ln 2/. The solution of the decay
part of Eq. 5 with D=0 is
ct = c0exp− t , 6
the well-known exponential decay function. The final solution
of Eq. 5 is
Fig. 2 Schematic view of an iontophoresis laser-Doppler perfusion
flow probe. Typical dimensions are: probe, diam 10 to 20 mm and
height 5 to 10 mm; fiber separation, 250 m. The diffusion can be
considered as monodimensional.
Fig. 3 The diffusion function, Eq. 4, plotted as a function of time for
several values of the depth as the parameter. Q=1 and D=0.001, a
without decay factor and b with decay constant =0.05. All vari-
ables and parameters are dimensionless here.
de Mul et al.: Diffusion model for iontophoresis measured by laser-Doppler…
Journal of Biomedical Optics January/February 2007  Vol. 121014032-3
Downloaded From: https://www.spiedigitallibrary.org/journals/Journal-of-Biomedical-Optics on 1/8/2019




exp− z24Dt − t . 7
This expression can be derived analytically using Laplace-
transformation techniques. The validity can be verified by the
insertion of Eq. 7 into Eq. 5. Figure 3b presents a sketch
of this solution for a nonzero value of the decay constant .
A comparison of these two figures shows a faster decrease
from maximum toward zero when we include the decay func-
tion into the expression.
The maximum of the function of Eq. 7 is found at
tmax =
1
4− 1 +1 + 2z2D  , 8
which reduces to z2 / 4D when  is very small i.e., slow
washout. The actual amplitude of the maximum can be found
by insertion of tmax in Eq. 7.
The next step assumes that the flow, as measured using
laser-Doppler perfusion flowmetry, is proportional to the con-
centration of administered drug molecules. This technique
measures the average blood flow F, which can be considered
as the averaged product of the concentration of moving red
blood cells and their velocities see Sec. 3 for experimental
details. According to our remarks in Sec. 1, we assume that
the excess blood flow F upon drug injection, i.e., the in-
crease of the flow above its level in resting conditions, is
proportional to the actual concentration of drug molecules.




exp	− z24Dt − t
 , 9
with Q0 as a constant related to the maximum value. We
adopted this expression for comparison with our experimental
data. In this way, the variable z represents an average depth
for the diffusion and decay process to take place.
Normally in iontophoresis, a series of shots is delivered
instead of a single shot. For repeated shots, the start condition
of zero concentration at all depths is not valid any more. This
may lead to a process of saturation, since the concentration at
low depths will increase with time, which eventually at high
concentrations might hamper new molecules to diffuse in-
ward. Another cause for saturation might be the limited ca-
pacity of the vessel wall to incorporate iontophoresis mol-
ecules, which might reduce the flow. As a first approximation,




exp− n − 1s
Q0
Dtn
exp	− z24Dtn − tn
 ;
tn = t − n − 1t , 10
where n stands for the shot number n=1. . .N, s is a constant
accounting for the saturation effect, tn is the time of the nth
shot, and t is the time interval between the shots. The sum-
mation is taken for positive tn values only. When s is zero, all
shots contribute equally, albeit time-shifted and the time
record will start smoothly. When s is much larger than unity,
only the first shot contributes and the time record starts more
abruptly.























with s, C, 	1, and 	2 as the parameters to be fitted. The pa-
rameter 	1 combines the model parameters z, which here has
a role of an “effective perfusion depth,” and D, the “apparent
diffusion constant.” Larger 	1 and 	2 values indicate slower
diffusion and slower decay or washout, respectively. The
constant th is included for dimensional purposes. It is taken as
half of the period, over which we perform the fitting process.
All times are measured from the start of the first shot tbegin.
Since in the protocols the duration of each shot is finite no
delta-like pulses, we took that into account by dividing each
shot into short subsequent subshots, calculating the contribu-
tion of each subshot using time shifting, and summing up all
those partial contributions.
We applied as the fitting scheme: minimization of the stan-
dard 
2 value, calculated from the squared differences be-
tween the measured values and the corresponding function
values, each divided by the squared standard deviation  at
that measured value, and summed over all measured points.
The summation extends over the time region between the
starting point tbegin of the iontophoresis and a chosen time
point when the measured values have returned to the level of
the resting flux values or when the occlusion starts. We cal-
culated the standard deviations in each measuring point from
the deviations of the measured values and calculated values
using a cubic polynomial approximation, averaged over a
relatively large number about −60 to +60 of surrounding
measuring points. The 
2 fit was performed by repeated sub-
sequent stepwise variation of each parameter around its actual
value, i.e., at that value, and at the value plus or minus the
step size, respectively. When in that process the smallest 
2
value appeared at one of these three parameter values, we
adopted that value as the new “actual value” and multiplied
the parameter step size with a factor 1 / 2, 2, or again 2,
respectively. To avoid being trapped in local minima during
the fitting process, we frequently multiplied the step sizes by
a factor of 10 or 100. The fit was continued until eventually
no relative change larger than 10−6 in 
2 was observed. To
start the fitting process, we inserted initial parameter values
manually or by using a coarse first estimation e.g., s=0.5,
and 	1 and 	2 equal to the apparent rise time or decay time of
the response signal. Since for the model the maximum value
cannot be calculated analytically, one might take the apparent
maximum of the response curve as the default starting value.
For an ideal fit, the reduced 
2, calculated from that stan-
dard 
2 by division by the difference of the number of mea-
sured points and the degrees of freedom the number of model
variables, actually 4, should approach unity as its minimum
value. When one of the parameters is varied until the reduced

2 equals the minimum value +1, that variation indicates the
standard deviation  in that parameter value. This  was cal-
culated afterward for all parameters, for each individual re-
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cording. For each group of subjects, the standard deviation
was calculated afterward by standard methods.
We included an option for a Gaussian weighting filter
fcorrt for the points:
fcorrt = exp− t/th2; th = tend − tbegin/2, 12
with tbegin and tend as the starting and end time points of the
fit, respectively all times are measured from the starting
point. However, it turns out that applying this filter has only
a slight effect on the resulting parameter values. This can be
understood by realizing that most significant contributions to

2 appear for small times t.
3 Measurements
Skin perfusion was measured by a Periflux 4000 laser-
Doppler system in combination with a Periflux tissue heater
set to 31°C PF4005, Peritemp, with all equipment from Per-
imed, Sweden. A laser beam wavelength of 780 nm is con-
ducted through optical fibers to illuminate the skin. As the
precise investigated volume is unknown, the signal collected
by the returning fiber is expressed in arbitrary units and re-
ferred to as flux PU. The vascular measurements were per-
formed with the subjects in a sitting position, their forearms
on a soft pillow at heart level, in a temperature-controlled
room T=23.4±0.5°C. Tissue temperature was recorded
during the measurements. Caffeine-containing drinks and
smoking were not allowed 2 h prior to the test.
A special iontophoresis probe PF481-2, Perimed, Sweden
containing a thermostatic probe holder was placed on the dor-
sal side of the middle phalanx of the third finger. A second
probe was placed at the first phalanx of the same finger and
measured the blood perfusion without being influenced by the
administration of the drugs.
A battery-powered iontophoresis controller PeriIont 382,
Perimed, Sweden was used to provide a direct current for
drug iontophoresis. The monitor’s signal processing electron-
ics calculates the zero and first moments, M0 and M1, of the





nSd; n = 0,1, 13
with 1 and 2 as the bandwidth limits set at 20 Hz to
12 kHz. This calculation is done in the time domain, and
corresponds to the zero-time autocorrelation values of the sig-
nal and its derivative, respectively. From M1t the perfusion
flow is obtained after division normalization with the square
of the total reflection from the sample. M0t can be consid-
ered as a measure for the concentration of moving scattering
particles red blood cells. In this study, we did not use this
function. A PC equipped with a data-acquisition subsystem
recorded the analog outputs of the monitor at a rate of 40
measurements per second. The data files were processed for
conversion from mV to perfusion units PU by division with
the gain factor of the instrument 10 mV/PU. Afterward, the
data were averaged per 40 samples to remove heart beat fluc-
tuations. This resulted in data at 1-s intervals.
The laser-Doppler perfusion measurements were per-
formed using a standardized protocol,2,3,10 including:
• resting flow, for a duration tr
• N shots, with current I, each with a duration of ts and
with time intervals of ti measured between the respec-
tive start times of the shots
• at about 5 to 10 min after the end of the last shot, start of
an arterial occlusion for 3 min
• release of the occlusion, followed by a measurement of
the return to resting flow condition.
The occlusion period provided the biological zero signal
level. This level was subtracted from the perfusion signal be-
fore all further calculations.
Women with Caucasian skin type participated in this study:
25 women with a history of early onset preeclampsia and 23
healthy women with uncomplicated pregnancies. Not all re-
cordings appeared useful; a few recordings from both groups
had to be discarded due to disturbing signal artifacts. Pre-
eclampsia was defined according to the criteria of the Inter-
national Society for the Study of Hypertension in Pregnancy:
the appearance of a diastolic blood pressure DBP
90 mmHg measured at two occasions at least 4 h apart in
combination with proteinuria 300 mg/24 h or 2+ dipstick
developing after a gestational age of 20 weeks in a previously
normotensive woman. All women had singleton pregnancies
and were tested between 3 and 11 months postpartum. None
of the participants used any medication during the studies.
Women with pre-existing hypertension blood pressure before
20 weeks of gestation 140/90 mmHg or using antihyper-
tensive medication, diabetes mellitus, renal disease, preec-
lampsia in a previous pregnancy, or who were using vaso-
active drugs were excluded. The experimental procedure and
the population of subjects were previously described in detail
by Blaauw et al.5 In Table 1 we summarized the experimental
settings.
Table 1 Experimental settings. ACh=acetyl choline chloride,
CH33NClCH2CH2OCOCH3, M=182, in Miochol. SNP=sodium ni-
troferricyanideIII, Na2FeCN5NO ·2H2O, M=298. 
1 100 or
200 s in later measurements; 0 between begin times of shots.
Code ACh SNP
Subjects Number Number
Preeclampsia patients postpartum PPP 22 20
Controls healthy postpartum PPC 18 21
Resting flow measurement, duration s 6001 6001
Shot duration s 20 20
Current mA, anodal A, or cathodal
C
0.1 A 0.2 C
Number of shots 7 9
Shot interval s 0 60 90
Duration of occlusion s 180 180
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4 Results and Discussion
In Fig. 4 we present a typical example of a time recording of
one of the patients. It is seen that upon drug administration,
the flux increases sharply from the resting flow level, fol-
lowed by a much slower decrease toward the resting flow
level. The effect of the multiple shots is clearly seen.
We discuss the results in two ways. First, in physical
terms, which comprises the validation of the fitting procedure,
together with an evaluation of the reduced 
2 values. Second,
we briefly discuss the clinical relevance.
4.1 Physical Analysis
The model was fitted to all recordings of the two groups. For
these measurements, we did not use the Gaussian fitting filter,
given in Eq. 12. In Fig. 4 the fitted model is shown, together
with the measured data and the resting flux line. The fitting
program offers the option to include the starting time point as
an extra parameter, but with these measurements we fixed the
starting time to the values given in Table 1.
After fitting the model to the individual recordings, aver-
aged values were calculated, in which the reduced 
2 values













where P stands for each of the parameters or results of the fit,
and i counts for the subjects in the groups i=1. . .N. The
approximated standard deviation in P was calculated using
the standard formula.
In Fig. 5 we show an overview of the fitted parameters for
one of the groups. From that figure it is seen that all 
red
2
values are close to the ideal value of 1. All parameter values
show a consistent behavior, apart from:
• the function value C which is distinct from the apparent
curve maximum M, which varies significantly
• the shot saturation constant, which is larger than 106 the
artificially set maximum for the parameter values during
the fitting process for subject 9. This subject was ex-
cluded from the calculation of the average of that param-
eter over the group.
Additionally, with some subjects in other groups, the decay
parameter 	2 may rise above that maximum value during the
fit. Those subjects were also excluded in the calculation of the
averaged 	2 value of that group. Table 2 shows an overview of
the number of excluded subjects per group. It is remarkable,
however, that while one of the parameters grows to a large
value, the other parameters remain within limits, comparable
to the values obtained with other subjects. We have to inves-
tigate that point more closely.
In Fig. 6 the averaged values of the fit parameters are
shown. The error bars indicate the standard deviations in these
averages or standard errors in the means. Recalculation of
the averages, without applying the 
2 weighting, resulted for
all variables and all groups in shifts 5%, thus within the
standard deviation range. The averaged 
2 values over the
four groups are between 1 and 2.5, indicating fits with devia-
tions from the measured data, ranging from equal to about
twice the standard deviation in those measured data. We con-
clude that the fitting procedure worked satisfactorily.
From Fig. 6 it is seen that the groups of patients show
larger values for the diffusion time constant 	1 than the cor-
responding control groups, meaning that the diffusion will
take place over a longer time scale. The values for 	2 show a
pattern that indicates that with ACh the removal or decay
Fig. 4 Typical fit of a laser-Doppler iontophoresis recording of SNP
administration, together with the resting flux line extrapolated from
t200 s and the fitted line. Parameters: 
red
2 =1.15; 	1=76±10 s; 	2
=408±30 s; and s=0.029±0.014.
Fig. 5 Overview of results for the fitted parameters for one of the four
groups of subjects: the patients with SNP as the administered drug
PPP-SNP. Points: =	1; =	2; =s; =max/Frest ; =
red
2 .
max = maximum value of the fitted curve; Frest=resting flux value.
Lines drawn to guide the eye. Subject 9 has an s-value 106 i.e., first
shot contributes only.
Table 2 Excluded subjects in the groups for the calculation of the
group average of the parameters s and 	2, respectively.
PPP-ACh PPC-ACh PPP-SNP PPC-SNP
s105 3 of 21 1 of 18 1 of 19 2 of 20
	2105 s 1 of 21 1 of 18 0 of 19 2 of 20
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time is longer than with SNP. The shot saturation constant s is
large for ACh but small for SNP. This means that with SNP,
all shots do contribute, but for with ACh, only the first few
shots contribute. The values for tM also reflect this behavior:
with SNP it takes more time to reach the maximum than with
ACh. The ratios of the maxima and the resting fluxes appear
to show differences for the ACh-administered control group
persons, compared with the other groups.
From the time parameter 	1 we may calculate the apparent
diffusion coefficient D, using Eq. 10, provided we insert a
proper value for the “effective perfusion depth z.” Assuming
z=1 mm, we obtain diffusion coefficient values as given in
Table 3.
Also in Table 3, half-life decay times T1/2, from T1/2
=ln 2/=ln 2	2, are shown. These times indicate the time
needed for removal of half the actual concentration.
We compared the values for the diffusion coefficient with
the literature data. From Flynn’s tables8 for normal not elec-
trically sustained diffusion over membranes, we can estimate
permeability constants and from those, using Eq. 1, diffu-
sivities diffusion constants, which are in the order of
10−10 cm2/s. To do this, we calculated the diffusivity D for
Flynn’s whole list of permeability data of about 100 com-
pounds, using Eq. 1 with h=0.5 mm,9 and interpolated the
results at the molecular weight values of ACh and SNP. The
logarithmic relation in Eq. 6 of Ref. 9, including the mo-
lecular weight, led to similar results.
When we choose z=1 mm, the diffusion coefficients for
iontophoresis diffusion, which is electrically sustained, are
about 4 orders of magnitude larger than the free, nonsustained
diffusion coefficient values. This may lead to the establish-
ment of an “iontophoresis diffusion amplification factor,”
which could be about 104, using the values indicated earlier.
4.2 Clinical Analysis
A primary analysis of the microvascular measurements, based
on manual estimation of the ratio of maximum flux and rest-
ing flux, has been presented by Blaauw et al.5 Using the
model, we are able to add data about the time constants for
diffusion and decay, 	1 and 	2, respectively, the saturation
constant s, maximum flux, vasodilatation expressed as relative
increase in flux from the resting flux obtained by the model
Figs. 7 and 8, and the time interval from start of the ionto-
phoresis and time of reaching maximum flux. Figures 7–9
were obtained without the 
2 weighing.
We used a Komolgorov-Smirnov test to assess the normal-
ity of the data. Since all parameters turned out to be non-
normally distributed, the nonparametric Mann-Whitney test
was used for testing group differences. To investigate how
well the endpoint parameters for the vasodilatation obtained
manually and using the model fit agreed, the difference be-
tween the two methods was plotted against the average of
both methods Fig. 9. We used the SPSS-software package,
version 12.0.1. Significance was accepted at p0.05.
Microvascular reactivity was tested in 25 recently pre-
eclamptic women and 23 controls. Of these 96 measurements,
18 were discarded, as they did not fit in the model, resulting in
a total of 21 measurements in the PPP-ACh group, 19 mea-
surements in the PPP-SNP group, 18 measurements in the
PPC-ACh group, and 20 measurements in the PPC-SNP
group. In the case of the parameters 	2 and s, few measure-
ments were discarded, as they fell totally out of range Table
2.
With respect to iontophoresis of ACh, women with recent
preeclampsia showed significantly higher values for vasodila-
tation Fig. 8, as we presented and discussed before. No sig-
Fig. 6 Averaged parameter values over the four groups of subjects,
calculated with 
2 weighing. max=maximum value of the curve. rest
=resting flux. Also included: time tM from start of iontophoresis to the
top of the curve. Error bars indicate standard deviations in the aver-
aged values.
Table 3 Apparent diffusion coefficients for effective perfusion depths of 1 mm, and half life times for
decay or removal with standard deviations of the average; values calculated with 
2 weighing.
PPP-ACh PPC-ACh PPP-SNP PPC-SNP
Value SD Value SD Value SD Value SD
	1 s 214 73 130 38 324 55 156 34
D 10−6 cm2/s 11.7 4.0 19.2 5.6 7.7 1.3 16.0 3.5
	2 s 5511 1970 3515 1415 348 118 1121 369
T1/2 s 3820 1366 2436 981 241 82 777 256
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nificant differences were noticed for the other parameters
Figs. 7–9.
With respect to iontophoresis of SNP, significantly higher
values for 	1 Fig. 7a were found, whereas lower values for
	2 Fig. 7b were noticed for the formerly preeclamptic
group compared to the controls. This indicates that diffusion
of SNP takes a longer time and the decay or washout of SNP
in the formerly preeclamptic group takes shorter times than in
the control group.
5 Conclusions
We introduce a physical model to describe the iontophoresis
process, as applied to normal and preeclamptic pregnancies.
We derive characteristic times for diffusion and for decay
washout and/or saturation. We are able to properly account
for the subsequence of iontophoresis shots, used in adminis-
tering the drugs to the tissue of the subjects.
We see differences in the time recordings of the groups of
patients and control persons, and in the type of administered
material. These differences are quantified using the variables
Fig. 7 Measured data for the diffusion time constant 	1, the decay
time constant 	2, and the saturation constant s, with probability values
p.
Fig. 8 Vasodilatation percent, or the maximum excess flux above
the resting flux, relative to that resting flux level.
Fig. 9 Difference between vasodilatation percent obtained manually
and using the model procedure, plotted against the average of the two
methods.
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of the physical model. Results of further investigations, in-
cluding other groups of patients, will be published elsewhere.
Frequently, iontophoresis experiments cannot easily be
compared due to differences in the clinical protocols adopted
by various experimentalists. We hope that this model might
help in the future when comparing and interpreting those ion-
tophoresis measurements, and in standardizing protocols for
measurements and procedures for analysis of the experimental
data.
As a general conclusion, this modeling of the iontophoretic
diffusion might offer the opportunity to derive diffusion coef-
ficients and time constants, which may provide a better insight
into iontophoretic processes in tissue.
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